This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’

Duracyte’s implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup’s marriage of biotechnology with electronics comes with on-board sensors that enable clinicians to monitor and control an implant’s drug production process. The post This Startup Aims to Upend Biologic Drug Production With Implantable ‘Cell Factories’ appeared first…

Read More

What Can Providers Do Differently to Get Paid Sooner?

A new report from PayZen found that providers collect just 31% of patient bills on average, even as patient payments account for a growing share of health system revenue. PayZen executive Tobias Mezger outlined how providers can improve the patient financial experience through clearer pre-care payment conversations and more flexible financing options. The post What…

Read More

When Patients Understand, Hospitals Grow

Hospitals who prioritize patient understanding achieve better operational outcomes. Higher surgical conversion rates, increased patient retention, and repeat engagement produce measurable performance gains. The post When Patients Understand, Hospitals Grow appeared first on MedCity News.

Read More

Journalists Unpack Latest on Vaccines, Vaping, and TrumpRx

KFF Health News chief Washington correspondent Julie Rovner discussed federal policy on vaccine research, vaping, and drug access on Science Friday on May 8. Rovner also discussed the Supreme Court decision on the abortion pill mifepristone on NPR’s Morning Edition on May 5. Click here to hear Rovner on Science Friday. Click here to hear…

Read More

Under FDA Clinical Hold, Aardvark Therapeutics Seeks Path Forward for Metabolic Drug

The full FDA clinical hold formally halts all tests of Aardvark Therapeutics’ drug for Prader-Willi syndrome, a rare inherited metabolic disorder that leads to excessive eating. Earlier this year, Aardvark voluntarily paused all tests of its small molecule after a cardiovascular problem emerged in a healthy volunteer. The post Under FDA Clinical Hold, Aardvark Therapeutics…

Read More